4//SEC Filing
CORRIGAN MARK 4
Accession 0000950170-24-097286
CIK 0001631574other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 6:00 PM ET
Size
7.3 KB
Accession
0000950170-24-097286
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Ordinary Shares
2024-08-12+32,230→ 32,230 total - Award
Share Option (right to buy)
2024-08-12+64,460→ 64,460 totalExercise: $5.37Exp: 2029-08-12→ Ordinary Shares (64,460 underlying)
Footnotes (2)
- [F1]The reporting person was granted this restricted share unit award (RSU) pursuant to the 2024 Non-Employee Director Compensation Policy. The RSU vests as to 50% on each of (i) the earlier of the Company's 2025 annual general meeting or August 12, 2025; and (ii) the earlier of the Company's 2026 annual general meeting or August 12, 2026.
- [F2]The reporting person was granted this option pursuant to the 2024 Non-Employee Director Compensation Policy. The option vests as to 12.5% on a quarterly basis beginning August 12, 2024, through the two-year period following the grant date.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001250661
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 6:00 PM ET
- Size
- 7.3 KB